Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 61, pseudogene (RNU6-61P)
- Target
- RNU6-61P
- Molecular classification
- Other (Pseudogene, Non-coding RNA gene family)
01
Overview
RNU6-61P is a non-coding RNA pseudogene belonging to the U6 small nuclear RNA gene family. While the active U6 snRNA molecule plays a critical role in splicing pre-mRNA within the spliceosome[1][2][3], pseudogenes like RNU6-61P do not produce functional RNA transcripts or proteins due to accumulated mutations. Such pseudogenes are remnants of genomic evolution, and while they may contribute to genome structure or evolution, they do not function in canonical cellular processes nor serve as drug targets or biomarkers[5]. The U6 snRNA is noted for its nuclear localization and essential spliceosomal function, but these attributes are not relevant to the RNU6-61P pseudogene itself[1][2][3]. No evidence supports the use of RNU6-61P in therapeutics, drug development, biomarker selection, or disease association, and its inclusion as a molecular target would be incorrect. The correct "target" in biological or therapeutic contexts would be the functional U6 snRNA, not its pseudogene variants such as RNU6-61P[5].
- Other names
- RNU6-61RNU6-61PRNA, U6-61 small nuclear, pseudogene
02
Biological functions
Other (No known biological function; parent functional gene U6 snRNA is involved in RNA splicing, but the pseudogene itself is non-functional[1][3])
03
Disease associations
Other (No known disease association; the functional U6 snRNA may be misregulated in cancer, but pseudogenes are not implicated[2][5])
Beyond the preview
Go deeper on RNA, U6 small nuclear 61, pseudogene (RNU6-61P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 61, pseudogene (RNU6-61P).